` NAUT (Nautilus Biotechnology Inc) vs S&P 500 Comparison - Alpha Spread

NAUT
vs
S&P 500

Over the past 12 months, NAUT has underperformed S&P 500, delivering a return of +13% compared to the S&P 500's +14% growth.

Stocks Performance
NAUT vs S&P 500

Loading
NAUT
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NAUT vs S&P 500

Loading
NAUT
S&P 500
Difference
www.alphaspread.com

Performance By Year
NAUT vs S&P 500

Loading
NAUT
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Nautilus Biotechnology Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Nautilus Biotechnology Inc
Glance View

Nautilus Biotechnology, Inc. operates as a life sciences company. The company is headquartered in Seattle, Washington and currently employs 113 full-time employees. The company went IPO on 2020-08-07. The firm is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The firm focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The firm is developing a prototype of a single-molecule instrument, Proteomic Analysis System. The Company’s Proteomic Analysis Platform leverages a nanofabricated, single-molecule protein array, multi-cycle imaging, and machine learning analysis to identify and measure the proteome with sensitivity and scale.

NAUT Intrinsic Value
Not Available
Back to Top